WHD:NYSECactus, Inc. Class A Common Stock Analysis
Data as of 2026-05-28 - not real-time
$60.64
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Cactus, Inc. delivered a stellar Q1 2026, with revenue surging 38.5% YoY to $388.3 million and non‑GAAP EPS beating consensus at $0.70. The stock now trades at $60.64, comfortably above its 20‑day SMA ($57.79) and 50‑day SMA ($53.67), while the RSI sits at 61.5 and the MACD histogram remains positive, signaling a bullish technical backdrop bolstered by increasing volume and an “Extreme Greed” sentiment reading.
However, the valuation appears stretched: the trailing P/E of 56.7 far exceeds the industry average of 20.7, and the DCF‑derived fair value of $51.98 suggests a discount of roughly 15% relative to the current price. Despite a modest 0.92% dividend yield and a sustainable payout ratio of 51%, the high beta (~1.2) and 30% 30‑day volatility point to heightened market risk, while the sector’s cyclical exposure to oil‑field activity adds further uncertainty. Analysts remain optimistic (median target $66), but the limited upside of ~4% and a notable max drawdown of 30% warrant a cautious stance.
However, the valuation appears stretched: the trailing P/E of 56.7 far exceeds the industry average of 20.7, and the DCF‑derived fair value of $51.98 suggests a discount of roughly 15% relative to the current price. Despite a modest 0.92% dividend yield and a sustainable payout ratio of 51%, the high beta (~1.2) and 30% 30‑day volatility point to heightened market risk, while the sector’s cyclical exposure to oil‑field activity adds further uncertainty. Analysts remain optimistic (median target $66), but the limited upside of ~4% and a notable max drawdown of 30% warrant a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical momentum but limited upside to resistance at $64.30
- Current price above DCF fair value
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue growth and earnings beat
- Forward P/E contraction to 17.6
- Analyst median target of $66 indicating upside
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained dividend with healthy cash flow
- Cyclical exposure to oil‑field spending
- Valuation gap versus DCF and peer multiples
Key Metrics & Analysis
Financial Health
Revenue Growth38.50%
Profit Margin13.03%
P/E Ratio56.7
ROE12.72%
ROA7.03%
Debt/Equity3.35
P/B Ratio3.4
Op. Cash Flow$345.1M
Free Cash Flow$93.8M
Industry P/E20.7
Technical Analysis
TrendBullish
RSI61.6
Support$53.30
Resistance$64.30
MA 20$57.79
MA 50$53.67
MA 200$47.51
MACDBullish
VolumeIncreasing
Fear & Greed Index92.34
Valuation
Fair Value$51.98
Target Price$63.22
Upside/Downside4.26%
GradeOvervalued
TypeGrowth
Dividend Yield0.92%
Risk Assessment
Beta1.18
Volatility33.67%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.